Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening.
Dysregulation of p27(Kip1) due to proteolysis that involves the ubiquitin ligase (SCF) complex with S-phase kinase-associated protein 2 (Skp2) as the substrate-recognition component (SCF(Skp2) ), frequently results in tumorigenesis. In this report, we developed a high-throughput screening system to identify small-molecule inhibitors of p27(Kip1) degradation. This system was established by ... tagging Skp2 with fluorescent monomeric Azami Green (mAG) and CDK subunit 1 (Cks1) (mAGSkp2-Cks1) to bind to p27(Kip1) phosphopeptides. We identified two compounds, linichlorin A and gentian violet that inhibited the interaction between mAGSkp2-Cks1 and p27(Kip1) . Further studies have shown that the compounds inhibited the ubiquitination of p27(Kip1) in vitro as well as p27(Kip1) degradation in HeLa cells. Notably, both compounds exhibited preferential antiproliferative activity against HeLa and tsFT210 cells compared with NIH3T3 cells and delayed the G1 phase progression in tsFT210 cells. Our approach indicates a potential strategy for restoring p27(Kip1) levels in human cancers. This article is protected by copyright. All rights reserved.
Cancer Sci.
Date: Aug. 02, 2013
PubMed ID: 23910095
View in: Pubmed Google Scholar
Download Curated Data For This Publication
158015
Switch View:
- Interactions 5